Abstract:Nitrogen-based heterocycles such as pyrazole, imidazole, 1,2,4-triazole, benzimidazole, and benzotriazole substituted fused pyran derivatives (6a-e, 8a-e, 10a-e, 12a-e & 14a-e) have been synthesized and tested for their in vitro anticancer efficacies against MCF7, A549 and HCT116 cancer cell lines. Among the compounds, 6e, 12a, 14b against MCF7, 12a, 12c, 12d, 14b-d against A549, and 8c, 8e against HCT116 displayed promising activity with the IC50 values in the range of 0.23 ± 0.12 to 32.14 ± 0.83 M. Among them, 6e, 14b, and 8c were identified as the most potent against MCF7, A549, and HCT116 with IC50 values of 12.46 ± 2.72 M, 0.23 ± 0.12 M, and 7.58 ± 1.01 M, respectively. Except for 12a and 14b, remaining all active compounds exhibited selective inhibitory activity on different cancer cell types. It has been identified that these compounds can change cellular and nuclear morphology and inhibit colony formation in the tested cancer cells. They also remarkably block/inhibit the cell cycle progression of cancer cells at various phases. DNA damage analysis and apoptosis studies revealed that these compounds have the potential to induce DNA double-strand breaks and apoptosis. In a time when breakthroughs in cancer treatment are fervently sought, the emergence of fused pyran derivatives as potent anticancer agents is of immense value. As we delve deeper into their mechanisms and optimize their properties, these compounds hold promise as a significant step forward in the ongoing battle against cancer. In silico ADMET properties of the potent compounds were assessed, revealing that all the compounds exhibited favorable pharmacokinetic and toxicological properties. Thus, this study not only contributes to the scientific understanding of heterocycle-based compounds but also resonates with the pressing need for innovative solutions to address the global challenge of cancer.

Furan-Triazine clubbed Schiff base derivatives: Computational insight and empirical precision against A-549 and MDA-MB-468 Carcinoma cells

1,3,5-triazine derivatives as potential anticancer agents against lung and breast cancer cell lines: Synthesis, biological evaluation, and structure-based drug design studies

1,2,3-triazole and chiral Schiff base hybrids as potential anticancer agents: DFT, molecular docking and ADME studies

Synthesis, anticancer evaluation, in‐silico ADMET and molecular docking studies for tailored pyrazolo‐benzothiazole hybrids

Novel Dibenzo[b,d]furan-1H-1,2,4-triazole Derivatives: Synthesis and Antitumor Activity.

Novel trifluoromethyl-thieno[2,3-b]pyridine-2-carboxamide and Schiff’s base derivatives and their anticancer activity

Synthesis and biological evaluation of Schizandrin derivatives as potential anti-cancer agents

Design and synthesis of novel 2-(4-(2-(dimethylamino)ethyl)-4H-1,2,4-triazol-3-yl)pyridines as potential antitumor agents.

Novel N-(3-ethynyl Phenyl)-6,7-bis(2-methoxyethoxy)Quinazoline-4-amine Derivatives: Synthesis, Characterization, Anti-cancer Activity, In-silico and DFT Studies

Synthesis, Biological Evaluation and Docking Studies of (E)-3-Aryl-2-(3,4,5-trimethoxybenzoyl) Acrylonitrile Derivatives as Anticancer Agents

Novel Fused Pyran Derivatives Induce Apoptosis and Target Cell Cycle Progression in Anticancer Efficacy against Multiple Cell Lines

Design, Synthesis and Characterization of novel 1,5- and 2,5-coumarin-4-yl-methyl regioisomers of 5-pyrazol-3-yl-tetrazoles as promising anticancer and antifungal agents

Target prioritization of novel substituted 5-aryl-2-oxo-/thioxo-2,3-dihydro-1 H-benzo[6,7]chromeno[2,3- d]pyrimidine-4,6,11(5 H)-triones as anticancer agents using in-silico approach

Synthesis, DFT, ADMET, and Docking studies of Novel Sulfonyl Piperidine Analogues containing 2,3-Dihydrobenzofuran-5-Carboxamide

Synthesis, characterization, anti-lung cancer activity, and in-silico studies of some novel triazole-based analogues as Pellizzari products

Synthesis and Biological Evaluation of Novel Furopyridone Derivatives as Potent Cytotoxic Agents against Esophageal Cancer

Design, Synthesis and Anticancer evaluation of Imamine-1,3,5-triazine derivatives

Synthesis, In Vitro Evaluation and Molecular Docking Studies of Novel Thiophenyl Thiazolyl-Pyridine Hybrids as Potential Anticancer Agents

Novel Coumarin-Piperazine-2(5h)-furanone Hybrids As Potential Anti-Lung Cancer Agents: Synthesis, Biological Evaluation and Molecular Docking Studies

Repositioning of acefylline as anti-cancer drug: Synthesis, anticancer and computational studies of azomethines derived from acefylline tethered 4-amino-3-mercapto-1,2,4-triazole

Design, Synthesis, Computational Docking and Biological Evaluation of Novel 4-Chloro-1,3-Benzoxazole Derivatives as Anticancer Agents